Fidelity Investments
HRMY icon

Fidelity Investments’s Harmony Biosciences HRMY Stock Holding History

Fidelity Investments’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$130M Buy
3,574,115
+416,476
+13% +$13.1M 0.01% 1123
2026
Q1 		$88.4M Buy
3,157,639
+44,827
+1% +$1.47M ﹤0.01% 1232
2025
Q4 		$116M Sell
3,112,812
-734,160
-19% -$24.1M 0.01% 1106
2025
Q3 		$106M Sell
3,846,972
-841,220
-18% -$29M 0.01% 1157
2025
Q2 		$148M Sell
4,688,192
-654,333
-12% -$21M 0.01% 949
2025
Q1 		$177M Buy
5,342,525
+12,623
+0.2% +$453K 0.01% 840
2024
Q4 		$183M Buy
5,329,902
+101,182
+2% +$3.48M 0.01% 858
2024
Q3 		$209M Sell
5,228,720
-9,184
-0.2% -$323K 0.01% 811
2024
Q2 		$158M Sell
5,237,904
-17,614
-0.3% -$530K 0.01% 869
2024
Q1 		$176M Sell
5,255,518
-21,307
-0.4% -$684K 0.01% 838
2023
Q4 		$170M Sell
5,276,825
-173,384
-3% -$4.84M 0.01% 808
2023
Q3 		$179M Sell
5,450,209
-20,038
-0.4% -$696K 0.02% 739
2023
Q2 		$192M Sell
5,470,247
-121,328
-2% -$4.19M 0.02% 737
2023
Q1 		$183M Buy
5,591,575
+8,847
+0.2% +$403K 0.02% 745
2022
Q4 		$308M Sell
5,582,728
-32,611
-0.6% -$1.79M 0.03% 550
2022
Q3 		$249M Buy
5,615,339
+188,557
+3% +$9.2M 0.03% 594
2022
Q2 		$265M Buy
5,426,782
+529,600
+11% +$23.8M 0.03% 605
2022
Q1 		$238M Buy
4,897,182
+689,583
+16% +$28.1M 0.02% 697
2021
Q4 		$179M Buy
4,207,599
+78,648
+2% +$3.13M 0.01% 847
2021
Q3 		$158M Sell
4,128,951
-812,576
-16% -$26.2M 0.01% 908
2021
Q2 		$139M Sell
4,941,527
-2,308,914
-32% -$69.3M 0.01% 981
2021
Q1 		$240M Sell
7,250,441
-676,183
-9% -$23.7M 0.02% 712
2020
Q4 		$274M Sell
7,926,624
-1,137,412
-13% -$45.9M 0.02% 622
2020
Q3 		$280M Buy
+9,064,036
New +$330M 0.03% 512

Other funds holding HRMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Fidelity Investments's HRMY Position: Q2 2026 in Review

Fidelity Investments increased its Harmony Biosciences (HRMY) stake by 13% in Q2 2026, buying an estimated $13.1M and bringing the position to 3,574,115 shares worth $130M. The position accounts for 0.01% of the portfolio, ranked #1123.

Fidelity Investments first reported a position in HRMY in Q3 2020 and has held it in 24 quarters since. The position peaked at $308M in Q4 2022. 327 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • Fidelity Investments held 3,574,115 shares of Harmony Biosciences worth $130M as of Q2 2026.
  • Fidelity Investments bought 416,476 Harmony Biosciences shares in Q2 2026, an estimated $13.1M.
  • Harmony Biosciences made up 0.01% of Fidelity Investments's portfolio in Q2 2026, its #1123 holding.
  • Fidelity Investments first reported a position in Harmony Biosciences in Q3 2020 and has held it in 24 quarters since.
  • Fidelity Investments's Harmony Biosciences position peaked at $308M in Q4 2022.
  • 327 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.